DANBURY, Conn., Aug. 25, 2025 /PRNewswire/ -- The National Organization for Rare Disorders (NORD®), the leading national nonprofit serving more than 30 million Americans with rare diseases, today ...
An England-wide study of over 58 million people has identified eight rare diseases that carry significantly increased risks for COVID-19-related mortality in fully vaccinated individuals. This ...
Rare diseases affect fewer than 200,000 people in the U.S., approximately 30 million individuals. Sadly, 3 out of 10 children with a rare disease won’t live to see their fifth birthday, yet the path ...
Rare disease registries are critical infrastructures for advancing clinical research and improving patient care in conditions where low prevalence and dispersed patient populations present significant ...
Pangaea Data, a company focused on detecting hard-to-diagnose diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically ...
The rare diseases treatment market is entering a pivotal phase marked by advanced therapeutic innovation, multi-stakeholder collaboration, and fundamental changes to research and ...
Crofelemer, a novel plant-based anti-secretory prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency (EMA) for both short bowel syndrome (SBS) and ...
Artificial intelligence is rapidly becoming medicine’s most powerful microscope, revealing patterns in human DNA that were ...
The FDA has outlined a new review process for drugs and biologics designed to treat ultrarare genetic diseases that would allow a single-arm trial, plus other supportive data, to serve as pivotal ...
Rare diseases are defined as conditions affecting fewer than 200,000 people in the US or less than 1 in 2,000 in Europe. 1-2 While each disease is individually rare, collectively, they represent a ...
Ipsen’s oral small molecule has failed to reduce the progression of a genetic disease that gradually turns tendons and ...